Abstract
The exhalation delivery system with Fluticasone (EDS-FLU) delivers steroid more posteriorly and superiorly within the nasal cavity than conventional nasal sprays. Placebo-controlled efficacy studies with EDS-FLU in nasal polyps (NAVIGATE I/II) included subjects with moderate/severe congestion despite using conventional nasal steroids. This is a new analysis of change in disease activity in the subgroup of patients who reported using an INS at the time of screening.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
